Naltrexone vs Acamprosate vs Disulfiram After Alcohol Detox: How the Medications Differ
Prepared for medical review.
Review status: Pending.
Completing alcohol detox answers an immediate question: how can withdrawal be managed safely? The next question is different: what treatment can reduce the chance of returning to harmful drinking?
In the United States, three medications are FDA-approved for alcohol use disorder: naltrexone, acamprosate and disulfiram. They do not work in the same way, and there is no single medication that is best for every patient.
Naltrexone: reducing alcohol reward and heavy drinking
Naltrexone blocks opioid receptors involved in some of alcohol’s rewarding effects. It can reduce craving and the risk of heavy drinking in some patients. Oral naltrexone is usually taken daily; extended-release injectable naltrexone is generally administered monthly.
Naltrexone may be particularly relevant when the clinical goal includes reducing the rewarding pull of alcohol or preventing a lapse from becoming a return to heavy drinking.
Acamprosate: supporting abstinence after withdrawal
Acamprosate has a different treatment target. It is generally used after withdrawal once abstinence has been achieved and is intended to help maintain abstinence while the brain adapts to life without alcohol.
Research has shown improved continuous abstinence compared with placebo in recently detoxified alcohol-dependent patients. The practical trade-off is adherence: acamprosate is taken multiple times per day.
Disulfiram: changing the consequences of drinking
Disulfiram works differently again. Rather than reducing reward or supporting neurochemical adaptation, it interferes with alcohol metabolism. Drinking alcohol while disulfiram is active can cause unpleasant and potentially serious reactions.
Its usefulness therefore depends heavily on motivation, adherence, supervision and careful medical assessment.
Which medication is better after alcohol detox?
That is usually the wrong question. A better question is: what problem are we trying to solve for this patient?
| Medication | Main treatment goal | Practical issue |
|---|---|---|
| Naltrexone | Reduce alcohol reward, craving or heavy drinking | Daily adherence for tablets; monthly return for injection |
| Acamprosate | Support continued abstinence after withdrawal | Multiple doses per day |
| Disulfiram | Deter drinking by producing an adverse alcohol reaction | Requires adherence and strong understanding of risks |
Meta-analytic evidence suggests that acamprosate is particularly useful for supporting abstinence, while naltrexone has evidence for reducing return to heavy drinking. That does not make one universally superior; it means the treatment target matters.
Why adherence matters as much as choosing the medication
A medication cannot help if it is not taken. That is especially important in alcohol recovery because the moment a person most wants to drink may also be the moment they are most tempted to stop taking medication.
That is one reason long-acting naltrexone delivery has attracted interest. Monthly injectable naltrexone reduces daily dosing decisions. Longer-acting implant strategies are designed to reduce those decisions further, although implants are not FDA-approved in the United States for alcohol use disorder and the implant-specific evidence base is smaller.
Medication does not replace counselling
None of these medications repairs relationships, changes social environments or teaches coping strategies. Medication and behavioural treatment address different parts of recovery.
For many patients, the strongest plan combines medication with counselling, recovery support and continued medical follow-up rather than treating detox as the end of care.
Where does the DeBinge model fit?
DeBinge is located in Nassau, The Bahamas. For suitable patients, its private treatment pathway combines medically managed withdrawal, long-acting naltrexone treatment and one year of counselling and recovery support.
The model is not based on the claim that naltrexone is the correct medication for every person with alcohol use disorder. Suitability must be assessed individually. The differentiator is the attempt to combine continuous pharmacological support with continuing counselling after detox.
For the broader post-detox explanation, see Alcohol Detox Is Only the Beginning: How Long-Acting Naltrexone May Support Recovery After Withdrawal.
Medical review
Prepared for medical review — Review status: Pending.
Medical reviewer: Dr Fergus Law, BSc, MBChB, FRCPsych, Consultant Psychiatrist specialising in substance misuse and addiction.
This article is educational and does not provide individual medical advice. Medication selection depends on medical history, liver and kidney function, opioid use, treatment goals, other medications and clinician assessment.